129823520672968750_306Apply medicationto financial fraud when Bo fell one-day losses, or over 70 million
Shanghai pharmaceutical plunge yesterday, holding the unit value advantage emerging growth, when Peng Bo of China two funds have to hit. After-hours data, three seats on the Agency to sell the unit for more than $ 200 million. But fund managers told reporters, selling it or not depends on the company values, as long as our basic operating without problems, share prices after smooth you can buy biboshi, penghua cheaper prices. AgencySeats sold sharply denies being the SFC investigation of Shanghai pharmaceutical concerned reported that reaction but investors remained severe. Company a-shares fell in early trading, fell, exchange rate of 5.89%. H share market, share prices also suffered badly, suddenly fell over in 35%, trading slightly rebounded, closing is still falling 24%. Shanghai pharmaceutical fell,So was again wounded by top holdings of institutional investors. According to buy Shanghai pharmaceutical institutions collectively in the first quarter, two ranks of which public placement Fund. Among them, Bo new funds when two consecutive quarter gallon Shanghai pharmaceuticals, to the end of the first quarter, holds 63.3993 million shares in total, ten current stockholders ' third. In addition, Peng holds 8.5 million new China value becomes the tenthFlow shareholders. Shanghai pharmaceuticals by $ 1.19/share yesterday, Bo new industry or one-day losses reached $ 75.44 million; penghua value advantage one-day losses at about $ 10 million. Yesterday the transaction information displayed in Shanghai Stock Exchange, sold top three seats among the three institutions, Trojan and sold more than 200 million Yuan, yesterday total turnover accounted for close to 30%, one ofFramed seats sold amounted to $ 108 million, selling list first, and at the same time, has a seat on the body yesterday to buy a $ 11.1764 million. Industry insiders said, because of emerging growth and Bo Peng Hua advantage shares are worth more than 10 billion, two of the net value of the Fund units of impact would not be significant. Fund Manager: selling is not a good choice for this "Stepping on mines ", Bo Fund said, Shanghai pharmaceutical-related reports in the media's content has yet to be confirmed; in the stocks in the investment process, Bo strictly fulfilled relevant investment research program; will actively continue to track the company's fundamentals change in the future. Penghua Fund says, although the Fund into Shanghai pharmaceutical top circulation of its shareholders, but because of the Fund's assets is large,The unit Fund position is not much, is unlikely to impact on the net. Compared with the funds of the Parties caution, fund internal cast and not throwing the idea also has some differences. "Fund managers are dealing with similar situations of emergency programmes. Shanghai pharmaceutical case is now occurring, we are all in the analysis of clear and specific reason given later after specific action programmes. Shanghai pharmaceuticalsHas not published the information, so it needs to wait for. "A fund company managers in Shanghai on the daily economic news reporter said. "The cast is still not throwing, entirely depends on the value of the company. If the current market situation did not affect the company's operations in the late, suddenly drop in stock prices are generally very good buying opportunities. For many companies, there areGovernance issues, particularly opaque fell as a result of information disclosure. I think Shanghai pharmaceuticals more outbreaks of internal contradictions, since it does not affect the performance of the current, when share prices after smooth you can buy biboshi, penghua cheaper prices. "Shenzhen, who asked not to be named said a Fund Manager. "Many of the lack of long-term investment value of stocksConditions, can become cheaper to buy many of the Fund's investment strategy, shuanghui development, constant on the governance structure of the group in question brings rapid decline in stock prices, but later appeared to steady rise, many funds have joined the ranks of buying at a later stage. Shanghai medicines appear to have similar, eager to sell is not a good choice. "The last Fund Manager saidRoad. �� Fund regulatory penalties not encourage bad behavior of listed companies in the industry veteran who told reporters, as a listed company, Shanghai pharmaceutical effect of the share prices, it should be suspended for the first time and instructions to prevent damage to investors. A pharmaceutical analyst at brokerage agreed that the internal governance structure of the company is difficult to change the basic value of Shanghai pharmaceutical, whenFell is in front of the inevitable reaction of investors in case of unknown cause. Therefore, lack of transparency is the analyst company difficult to give a more important cause of reasonable judgement. Connections through the daily economic news reporters yesterday a Fund Manager said: "shares a lot, we cannot avoid each. When we hold a company's industry and business situation
wow cd-key, could not avoid publicInformation disclosure on the issue, the Secretary, more difficult to influence the company's governance structure. This could be due to the institutional problems, but can also be said to be punished enough on the supervision contributed to the bad behavior of listed companies. "" On the whole, remained non-mature market system in China
Rift Platinum, whether it is the management system, market, and also industrialization, business operations, determines the investorExpected to have stability, which ensures that the volatility of the market is much larger than in mature markets. At the same time
TERA Gold, Black Swan is not a move, making the analysis of normal logic in our markets is difficult to work. "The person said. "Black Swan since listed companies cannot be avoided, we pay more attention to investment in blue-chip stocks. Accumulation of the perfection of the governance structure will take time, we only passLong-term tracking of a number of performance and stability, competitive companies grew up in the area, which are scarce resources on the stock market. "Some fund companies fund managers out of the Black Swan market way of life.
Others:
No comments:
Post a Comment